An update expert opinion on management and research strategies in Parkinson's disease psychosis

Author： Goldman Jennifer G   Vaughan Christina L   Goetz Christopher G  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.13, 2011-09, pp. : 2009-2024

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathological Gambling in Parkinson's Disease: An Update on Medical Management

By Pirritano Domenico   Plastino Massimiliano   Fava Antonietta   Cristiano Dario   Gallelli Luca   Colica Carmela   Bosco Domenico  

Current Psychopharmacology, Vol. 1, Iss. 4, 2012-11 ,pp. : 365-374

Bentham Science Publishers

Access to resources Recommend Favorite

Pimavanserin for the treatment of Parkinson's disease psychosis

By Friedman Joseph H  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1969-1975

Informa Healthcare

Access to resources Recommend Favorite

Levodopa-Induced Response Fluctuations in Patients with Parkinson’s Disease: Strategies for Management

By van Laar T.  

CNS Drugs, Vol. 17, Iss. 7, 2003-01 ,pp. : 475-489

Adis International

Access to resources Recommend Favorite

Pathophysiology and Treatment of Psychosis in Parkinson's Disease: A Review

By Zahodne Laura B.   Fernandez Hubert H.  

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 665-682

Adis International

Access to resources Recommend Favorite

Treatment of Psychosis in Parkinson’s Disease: Safety Considerations

By Fernandez H.H.   Trieschmann M.E.   Friedman J.H.  

Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. : 643-659

Adis International

Access to resources Recommend Favorite